Nicholas D Martinez
Overview
Explore the profile of Nicholas D Martinez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maroney S, Siebert A, Martinez N, Rasmussen M, Peterson J, Weiler H, et al.
J Thromb Haemost
. 2023 Jan;
21(3):639-651.
PMID: 36696221
Background: Tissue factor pathway inhibitor (TFPI) is the primary inhibitor of events initiating the blood coagulation pathway. Tfpi mice die during embryonic development. The absence of protease-activated receptor (PAR) 4,...
2.
Peterson J, Gupta S, Martinez N, Hardesty B, Maroney S, Mast A
J Thromb Haemost
. 2021 Nov;
20(3):565-573.
PMID: 34847292
Background: The factor V east Texas bleeding disorder (FVETBD) is caused by increased plasma tissue factor pathway inhibitor-α (TFPIα) concentration. The underlying cause is a variant in F5 causing alternative...
3.
Marar T, Martinez N, Maroney S, Siebert A, Wu J, Stalker T, et al.
J Thromb Haemost
. 2021 Jun;
19(9):2182-2192.
PMID: 34160126
Background: Tissue factor pathway inhibitor (TFPI) is an essential regulator of coagulation, limiting thrombin generation and preventing thrombosis. In humans and mice, TFPIα is the sole isoform present in platelets....
4.
Peterson J, Maroney S, Martinez N, Mast A
Arterioscler Thromb Vasc Biol
. 2021 Apr;
41(6):1942-1955.
PMID: 33827254
[Figure: see text].
5.
Siebert A, Maroney S, Martinez N, Mast A
J Thromb Haemost
. 2021 Mar;
19(6):1483-1492.
PMID: 33728763
Background: Tissue factor pathway inhibitor (TFPI) is an anticoagulant protein required for murine embryonic development. Intrauterine lethality of Tfpi mice occurs at mid- and late gestation, the latter of which...
6.
Maroney S, Westrick R, Cleuren A, Martinez N, Siebert A, Zogg M, et al.
Blood
. 2020 Aug;
137(2):258-268.
PMID: 32735640
Tissue factor pathway inhibitor (TFPI) inhibits proteases in the blood coagulation cascade that lead to the production of thrombin, including prothrombinase (factor Xa [FXa]/FVa), the catalytic complex that directly generates...
7.
Ellery P, Hilden I, Thyregod P, Martinez N, Maroney S, Gill J, et al.
Haemophilia
. 2019 Oct;
25(6):1083-1091.
PMID: 31608540
Introduction: Tissue factor pathway inhibitor (TFPI) is a naturally occurring anticoagulant found in plasma, where it circulates bound to lipoproteins, factor V (FV) or Protein S (PS), and in platelets....
8.
Maroney S, Peterson J, Zwifelhofer W, Martinez N, Yan K, Niebler R, et al.
Thromb Haemost
. 2019 Jan;
119(1):187.
PMID: 30597514
No abstract available.
9.
Maroney S, Peterson J, Zwifelhofer W, Martinez N, Yan K, Ra N, et al.
Thromb Haemost
. 2018 Oct;
118(11):2009.
PMID: 30357781
No abstract available.
10.
Maroney S, Peterson J, Zwifelhofer W, Martinez N, Yan K, Bercovitz R, et al.
Thromb Haemost
. 2018 Aug;
118(9):1545-1555.
PMID: 30086574
Background: Neonates undergoing cardiopulmonary bypass (CPB) surgery to correct congenital heart defects often experience excessive bleeding. Exposure of blood to artificial materials during CPB may activate coagulation, complement and inflammatory...